- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04683523
Anaerobic Exercises on Cardiac Workload, Peripheral Resistance and Lipid Index Among Grade 1 Hypertensive Young Adults
December 23, 2020 updated by: Ali Farhad, Ziauddin University
Anaerobic Exercise Impact on Cardiac Workload, Peripheral Resistance and Lipid Index Among Grade 1 HTN Patients
Impact of resistance exercises on grade I hypertensive patients were monitored on three outcome measures that were blood pressure, peripheral resistance and lipid index after 12 weeks of intervention
Study Overview
Study Type
Interventional
Enrollment (Actual)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan
- Ali Farhad
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- grade I HTN Age 20-40years Both male and female
Exclusion Criteria:
- unable to perform exercises Comorbidities like Diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Aerobic exercise training
|
Resistance training using dumbbells and therabands
|
|
Experimental: Anaerobic exercise training
|
Resistance training using dumbbells and therabands
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic blood pressure
Time Frame: From baseline to 12 weeks of training
|
Sphygmomanometer
|
From baseline to 12 weeks of training
|
|
Peripheral Resistance
Time Frame: From baseline to 12 weeks of training
|
Ankle Brachial Index
|
From baseline to 12 weeks of training
|
|
Lipid index
Time Frame: From baseline to 12 weeks of intervention
|
Hdl to ldl ratio blood test
|
From baseline to 12 weeks of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 17, 2017
Primary Completion (Actual)
February 16, 2018
Study Completion (Actual)
March 20, 2018
Study Registration Dates
First Submitted
December 19, 2020
First Submitted That Met QC Criteria
December 19, 2020
First Posted (Actual)
December 24, 2020
Study Record Updates
Last Update Posted (Actual)
December 28, 2020
Last Update Submitted That Met QC Criteria
December 23, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- Ziauddin U
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.